Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidrug resistance in non-small-cell lung cancer.
Scagliotti GV, Novello S, Selvaggi G. Scagliotti GV, et al. Among authors: selvaggi g. Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83. Ann Oncol. 1999. PMID: 10582146 Free article. Review.
The biology of epidermal growth factor receptor in lung cancer.
Scagliotti GV, Selvaggi G, Novello S, Hirsch FR. Scagliotti GV, et al. Among authors: selvaggi g. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4227s-4232s. doi: 10.1158/1078-0432.CCR-040007. Clin Cancer Res. 2004. PMID: 15217963 Review.
Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial.
Scagliotti GV, Kortsik C, Dark GG, Price A, Manegold C, Rosell R, O'Brien M, Peterson PM, Castellano D, Selvaggi G, Novello S, Blatter J, Kayitalire L, Crino L, Paz-Ares L. Scagliotti GV, et al. Among authors: selvaggi g. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6. Clin Cancer Res. 2005. PMID: 15701857 Clinical Trial.
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
Ceppi P, Longo M, Volante M, Novello S, Cappia S, Bacillo E, Selvaggi G, Saviozzi S, Calogero R, Papotti M, Scagliotti GV. Ceppi P, et al. Among authors: selvaggi g. J Thorac Oncol. 2008 Jun;3(6):583-9. doi: 10.1097/JTO.0b013e3181734f24. J Thorac Oncol. 2008. PMID: 18520795 Free article.
A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.
Rinaldi M, Crinò L, Scagliotti GV, Mosconi AM, De Marinis F, Gridelli C, Selvaggi G, Della Giulia M, Darwish S, Porrozzi S, Novello S, Cipri A, Bartolucci R, Calandri C, Tonato M. Rinaldi M, et al. Among authors: selvaggi g. Ann Oncol. 2000 Oct;11(10):1295-300. doi: 10.1023/a:1008334610955. Ann Oncol. 2000. PMID: 11106119 Free article. Clinical Trial.
601 results